Stereo Drugs Private Limited

Stereo Drugs Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24233TG2008PTC059539 Incorporated 06 June 2008 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2024
₹1.02 Cr
▼ 45% YoY
Net profit · FY 2024
₹1.59 Lakh
Net margin 1.6%
EBITDA · FY 2024
₹43.75 Lakh
EBITDA margin 43%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹3 Cr
Issued & subscribed
Satisfied charges
₹17.06 Cr
No open charges
Company age
18 yrs
Est. 2008
Directors on board
2
As per MCA filings

About Stereo Drugs Private Limited

Data last updated:

Stereo Drugs Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Aura Research And Remedies Private Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 June 2008 and has been in existence for over 18 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24233TG2008PTC059539. Its GSTIN is 29AAMCS1010P1Z1 (Karnataka). The company holds 3 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹3 Cr. It is led by directors Akkisani (Managing Director) and Prathima Arveti.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.165/P Aparna Palm Groves Ground Floor, Telangana.

As per the financials filed for FY 2024, the company reported a revenue of ₹1.02 Cr, a decline of 45% compared to the previous year. For the same year it recorded a net profit of ₹1.59 Lakh (net margin 1.6%) and EBITDA of ₹43.75 Lakh (EBITDA margin 43%). Revenue has declined at a compounded annual rate (CAGR) of 46% over three years and 45% over five years.

As per MCA filings, the company has satisfied charges of ₹17.06 Cr on record. Court records list 8 cases involving the company, including 8 filed against it; 1 case is pending.

Stereo Drugs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-06-0015074). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website stereodrugs.com.

Company details

CIN U24233TG2008PTC059539
Registration Number 059539
Incorporation Date 06 June 2008
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Parent Company Aura Research And Remedies Private Limited
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-KR-06-0015074

CIN history

Stereo Drugs has one previous CIN (Corporate Identification Number): U24233AP2008PTC059539. The current CIN is U24233TG2008PTC059539, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24233TG2008PTC059539Current
U24233AP2008PTC059539Previous

Recognitions & Rankings of Stereo Drugs

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-KR-06-0015074

Contact details

Stereo Drugs Private Limited's registered office is in Hyderabad, Telangana. Its website is stereodrugs.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Plot No.165/P Aparna Palm Groves Ground Floor, Phase – 1 Kompally Medchal Dist Telangana, Hyderabad, Telangana, India – 500100
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Stereo Drugs Private Limited, buy the company report.

Comprehensive company report
Stereo Drugs Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Stereo Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Stereo Drugs Private Limited, buy the company report.

Financials of Stereo Drugs Private Limited

FY 2025 filings available

Stereo Drugs Private Limited reported revenue of ₹1.02 Cr (down 45% YoY) for FY 2024.

Revenue · FY 2024
₹1.02 Cr ▼ 45%
Net profit · FY 2024
₹1.59 Lakh margin 1.6%
EBITDA · FY 2024
₹43.75 Lakh margin 43%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 45%
3 years · compounded
▼ 46%
5 years · compounded
▼ 45%
EBITDA CAGR growth
3 years · compounded
▼ 26%
5 years · compounded
▼ 24%

Revenue has declined at a compounded annual rate (CAGR) of 45% over five years, including a 45% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹43.75 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.59 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin43%
Net Profit Margin1.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Stereo Drugs Private Limited, buy the company report.

Board of directors of Stereo Drugs Private Limited

Stereo Drugs has 2 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Prathima ArvetiDirector17 Aug 20233 Years 3 MonthsCurrent
AkkisaniManaging Director01 Dec 20223 Years 11 MonthsCurrent

Auditor

Stereo Drugs Private Limited is audited by K.RAMBABU & Co. for the financial year 2022.

Auditor firmFinancial yearFirm registration number
K.RAMBABU & Co.FY 2022224953

Shareholding

The shareholding of Stereo Drugs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Stereo Drugs Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹17.06 Cr
Breakdown by lending institutions
Axis Bank Limited₹11.91 Cr
Corporation Bank₹5.14 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
17 Feb 201410483075Axis Bank Limited₹5.35 LakhSatisfied
31 Oct 201310459599Axis Bank Limited₹11.86 CrSatisfied
22 Aug 201110302538Corporation Bank₹5.14 CrSatisfied

To see the full charge records of Stereo Drugs Private Limited, buy the company report.

Total charge records: 3 View all charges

Credit ratings & regulatory alerts

Stereo Drugs Private Limited was last rated by Crisil on 27 Jul 2017.

Rating agencyRated onRating
Crisil27 Jul 2017

To see the full credit ratings and regulatory alerts of Stereo Drugs Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Stereo Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Stereo Drugs has 3 GST registrations: 1 active and 2 cancelled or inactive.

Total GSTINs
3
Active
1
Cancelled / inactive
2
GSTINStateStatusRegistered on
29AAMCS1010P1Z1KarnatakaActive01 Jul 2017

To see the full GST registrations and return filing status of Stereo Drugs Private Limited, buy the company report.

Recent activity

Stereo Drugs Private Limited has 11 board changes on record since 2009: 2 appointments and 9 cessations. The latest: Akkisani ceased to be Additional Director on 31 Jan 2024.

AGM
Stereo Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Stereo Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Akkisani ceased to be Additional Director.
Ceased
Anand Srinivas Katta ceased to be Additional Director.
Appointed
Prathima Arveti was appointed as Director.
Appointed
Akkisani was appointed as Managing Director.
Ceased
Kinthada Vijaya Lakshmi ceased to be Director.
Ceased
Kinthada Suryanarayana ceased to be Managing Director.
Charges
A charge registered on 31 Oct 2013 via Charge ID 10459599 with Axis Bank Limited was fully satisfied on 05 May 2022.
Charges
A charge registered on 17 Feb 2014 via Charge ID 10483075 with Axis Bank Limited was fully satisfied on 02 May 2022.
Charges
A charge with Axis Bank Limited of Rs. 11.86 Cr registered on 31 Oct 2013 with Charge ID 10459599 was modified on 02 Sep 2015.
Ceased
Narendra Babu Vutla ceased to be Director.

10 earlier events are in the company report.

Frequently asked questions

Stereo Drugs is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 June 2008 (18+ years old) and is registered under CIN U24233TG2008PTC059539.

Stereo Drugs has 2 current directors:

The latest financial statements of Stereo Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Stereo Drugs is 29AAMCS1010P1Z1, registered in Karnataka. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.

The CIN (Corporate Identification Number) of Stereo Drugs is U24233TG2008PTC059539. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Stereo Drugs has 8 court cases on record: 8 filed against it. 1 is pending. Most are in the district courts.

Stereo Drugs was incorporated on 06 June 2008, making it 18+ years old. It is registered with the Registrar of Companies, Hyderabad.

Akkisani ceased to be Additional Director on 31 Jan 2024. Anand Srinivas Katta ceased to be Additional Director on 22 Aug 2023. Prathima Arveti was appointed as Director on 17 Aug 2023. Stereo Drugs has 11 board changes on record in total.

Yes, Stereo Drugs is registered as a small enterprise under Udyam registration (number: UDYAM-KR-06-0015074).

Stereo Drugs can be reached through the website stereodrugs.com. Its registered office is in Hyderabad, Telangana, India.